Literature DB >> 28115701

Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.

Karin Hoppe-Seyler1, Felicitas Bossler1, Claudia Lohrey1, Julia Bulkescher1, Frank Rösl2, Lars Jansen3, Arnulf Mayer4, Peter Vaupel4, Matthias Dürst3, Felix Hoppe-Seyler5.   

Abstract

Oncogenic human papillomaviruses (HPVs) are closely linked to major human malignancies, including cervical and head and neck cancers. It is widely assumed that HPV-positive cancer cells are under selection pressure to continuously express the viral E6/E7 oncogenes, that their intracellular p53 levels are reconstituted on E6/E7 repression, and that E6/E7 inhibition phenotypically results in cellular senescence. Here we show that hypoxic conditions, as are often found in subregions of cervical and head and neck cancers, enable HPV-positive cancer cells to escape from these regulatory principles: E6/E7 is efficiently repressed, yet, p53 levels do not increase. Moreover, E6/E7 repression under hypoxia does not result in cellular senescence, owing to hypoxia-associated impaired mechanistic target of rapamycin (mTOR) signaling via the inhibitory REDD1/TSC2 axis. Instead, a reversible growth arrest is induced that can be overcome by reoxygenation. Impairment of mTOR signaling also interfered with the senescence response of hypoxic HPV-positive cancer cells toward prosenescent chemotherapy in vitro. Collectively, these findings indicate that hypoxic HPV-positive cancer cells can induce a reversible state of dormancy, with decreased viral antigen synthesis and increased therapeutic resistance, and may serve as reservoirs for tumor recurrence on reoxygenation.

Entities:  

Keywords:  cervical cancer; human papillomavirus; hypoxia; mTOR; tumor virus

Mesh:

Substances:

Year:  2017        PMID: 28115701      PMCID: PMC5307428          DOI: 10.1073/pnas.1615758114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

Review 1.  Glucose sensing by ChREBP/MondoA-Mlx transcription factors.

Authors:  Essi Havula; Ville Hietakangas
Journal:  Semin Cell Dev Biol       Date:  2012-03-03       Impact factor: 7.727

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

3.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

4.  Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells.

Authors:  Brita Singers Sørensen; Morten Busk; Nadine Olthof; Ernst-Jan Speel; Michael R Horsman; Jan Alsner; Jens Overgaard
Journal:  Radiother Oncol       Date:  2013-08-13       Impact factor: 6.280

5.  Human papillomaviruses as therapeutic targets in human cancer.

Authors:  Karin Hellner; Karl Münger
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 6.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

Review 7.  Current treatment strategies for inhibiting mTOR in cancer.

Authors:  Francesca Chiarini; Camilla Evangelisti; James A McCubrey; Alberto M Martelli
Journal:  Trends Pharmacol Sci       Date:  2014-12-11       Impact factor: 14.819

8.  Hypoxia attenuates the p53 response to cellular damage.

Authors:  Marcus Achison; Ted R Hupp
Journal:  Oncogene       Date:  2003-05-29       Impact factor: 9.867

Review 9.  Detection and characterization of tumor hypoxia using pO2 histography.

Authors:  Peter Vaupel; Michael Höckel; Arnulf Mayer
Journal:  Antioxid Redox Signal       Date:  2007-08       Impact factor: 8.401

10.  Immunotherapy of HPV-associated head and neck cancer: Critical parameters.

Authors:  Mevyn Nizard; Federico Sandoval; Cecile Badoual; Helene Pere; Magali Terme; Stephane Hans; Nadine Benhamouda; Clemence Granier; Daniel Brasnu; Eric Tartour
Journal:  Oncoimmunology       Date:  2013-04-16       Impact factor: 8.110

View more
  22 in total

Review 1.  HPV, hypoxia and radiation response in head and neck cancer.

Authors:  Eva-Leonne Göttgens; Christian Ostheimer; Paul N Span; Jan Bussink; Ester M Hammond
Journal:  Br J Radiol       Date:  2018-03-14       Impact factor: 3.039

2.  Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type.

Authors:  Lee B Sims; Keegan C Curry; Sindhu Parupalli; Gwynneth Horner; Hermann B Frieboes; Jill M Steinbach-Rankins
Journal:  Pharm Res       Date:  2019-03-13       Impact factor: 4.200

Review 3.  Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies.

Authors:  Michael T Spiotto; Cullen M Taniguchi; Ann H Klopp; Lauren E Colbert; Steven H Lin; Li Wang; Mitchell J Frederick; Abdullah A Osman; Curtis R Pickering; Steven J Frank
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

Review 4.  The Different Routes to Metastasis via Hypoxia-Regulated Programs.

Authors:  Ana Rita Nobre; David Entenberg; Yarong Wang; John Condeelis; Julio A Aguirre-Ghiso
Journal:  Trends Cell Biol       Date:  2018-07-23       Impact factor: 20.808

Review 5.  Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.

Authors:  Hassan A Alhazmi; Asim Najmi; Sadique A Javed; Shahnaz Sultana; Mohammed Al Bratty; Hafiz A Makeen; Abdulkarim M Meraya; Waquar Ahsan; Syam Mohan; Manal M E Taha; Asaad Khalid
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 6.  Tumor cell dormancy as an adaptive cell stress response mechanism.

Authors:  Laura Vera-Ramirez; Kent W Hunter
Journal:  F1000Res       Date:  2017-12-14

7.  Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines.

Authors:  Karin Hoppe-Seyler; Anja Honegger; Felicitas Bossler; Jasmin Sponagel; Julia Bulkescher; Claudia Lohrey; Felix Hoppe-Seyler
Journal:  Oncotarget       Date:  2017-11-15

8.  Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence.

Authors:  Apostolos Menegakis; Rob Klompmaker; Claire Vennin; Aina Arbusà; Maartje Damen; Bram van den Broek; Daniel Zips; Jacco van Rheenen; Lenno Krenning; René H Medema
Journal:  Cells       Date:  2021-03-10       Impact factor: 6.600

Review 9.  Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.

Authors:  Karin Hoppe-Seyler; Julia Mändl; Svenja Adrian; Bianca J Kuhn; Felix Hoppe-Seyler
Journal:  Viruses       Date:  2017-07-05       Impact factor: 5.048

10.  Commentary: Induction of Dormancy in Hypoxic Human Papillomavirus-Positive Cancer Cells.

Authors:  Anita Szalmás
Journal:  Front Oncol       Date:  2018-03-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.